Literature DB >> 14962875

Variations and increase in use of statins across Europe: data from administrative databases.

Tom Walley1, Pietro Folino-Gallo, Ulrich Schwabe, Eric van Ganse.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14962875      PMCID： PMC341388          DOI： 10.1136/bmj.328.7436.385

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  EURO-MED-STAT: monitoring expenditure and utilization of medicinal products in the European Union countries: a public health approach.

Authors: 
Journal:  Eur J Public Health       Date:  2003-09       Impact factor: 3.367

2.  Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy.

Authors:  J Larsen; A Vaccheri; M Andersen; N Montanaro; U Bergman
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

3.  Age, sex and practice variations in the use of statins in general practice in England and Wales.

Authors:  A Majeed; K Moser; R Maxwell
Journal:  J Public Health Med       Date:  2000-09
  3 in total
  37 in total

1.  Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe.

Authors:  T Walley; P Folino-Gallo; U Schwabe; E Van Ganse; P Stephens
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

Review 2.  [Use of prescription drugs in Spain and Europe].

Authors:  Juan Simó Miñana
Journal:  Aten Primaria       Date:  2011-10-22       Impact factor: 1.137

3.  Cardiovascular disease beyond the QOF.

Authors:  Roger Boyle; Steve Field; Nigel Sparrow; Amanda Howe; Imran Rafi
Journal:  Br J Gen Pract       Date:  2010-08       Impact factor: 5.386

4.  Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004).

Authors:  J L Hoven; F M Haaijer-Ruskamp; R H Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2004-12-09       Impact factor: 2.953

5.  Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy.

Authors:  Mirko Di Martino; Luca Degli Esposti; Pierfrancesco Ruffo; Silvia Bustacchini; Alessandro Catte; Alessandra Sturani; Ezio Degli Esposti
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

6.  HMG CoA reductase inhibitors and impotence: two case series from the Spanish and French drug monitoring systems.

Authors:  Alfonso Carvajal; Diego Macias; María Sáinz; Sara Ortega; Luis H Martín Arias; Alfonso Velasco; Haleh Bagheri; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 7.  Predicting the oxidative metabolism of statins: an application of the MetaSite algorithm.

Authors:  Giulia Caron; Giuseppe Ermondi; Bernard Testa
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 8.  Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Argirios Tsantes; Nikolaos M Sitaras
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

9.  Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study.

Authors:  Henriette Thisted Horsdal; Anne Vingård Olesen; Christiane Gasse; Henrik Toft Sørensen; Robert C Green; Søren Paaske Johnsen
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

10.  Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.

Authors:  Brian Godman; Ulrich Schwabe; Gisbert Selke; Björn Wettermark
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.